Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1993 1
1998 1
1999 1
2000 2
2001 2
2002 1
2003 2
2004 1
2007 2
2008 11
2009 5
2010 2
2011 8
2012 12
2013 9
2014 11
2015 14
2016 7
2017 11
2018 3
2019 8
2020 19
2021 20
2022 22
2023 19
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

170 results

Results by year

Filters applied: . Clear all
Page 1
Acquired hemophilia A: Updated review of evidence and treatment guidance.
Kruse-Jarres R, Kempton CL, Baudo F, Collins PW, Knoebl P, Leissinger CA, Tiede A, Kessler CM. Kruse-Jarres R, et al. Among authors: tiede a. Am J Hematol. 2017 Jul;92(7):695-705. doi: 10.1002/ajh.24777. Epub 2017 Jun 5. Am J Hematol. 2017. PMID: 28470674 Free article. Review.
Emicizumab prophylaxis in patients with acquired haemophilia A (GTH-AHA-EMI): an open-label, single-arm, multicentre, phase 2 study.
Tiede A, Hart C, Knöbl P, Greil R, Oldenburg J, Sachs UJ, Miesbach W, Pfrepper C, Trautmann-Grill K, Holstein K, Pilch J, Möhnle P, Schindler C, Weigt C, Schipp D, May M, Dobbelstein C, Pelzer FJ, Werwitzke S, Klamroth R. Tiede A, et al. Lancet Haematol. 2023 Nov;10(11):e913-e921. doi: 10.1016/S2352-3026(23)00280-6. Epub 2023 Oct 16. Lancet Haematol. 2023. PMID: 37858328 Clinical Trial.
International consensus recommendations on the management of people with haemophilia B.
Hart DP, Matino D, Astermark J, Dolan G, d'Oiron R, Hermans C, Jiménez-Yuste V, Linares A, Matsushita T, McRae S, Ozelo MC, Platton S, Stafford D, Sidonio RF Jr, Tiede A. Hart DP, et al. Among authors: tiede a. Ther Adv Hematol. 2022 Apr 2;13:20406207221085202. doi: 10.1177/20406207221085202. eCollection 2022. Ther Adv Hematol. 2022. PMID: 35392437 Free PMC article. Review.
Immunotherapy of acquired hemophilia A.
Tiede A. Tiede A. Hematology Am Soc Hematol Educ Program. 2023 Dec 8;2023(1):19-23. doi: 10.1182/hematology.2023000461. Hematology Am Soc Hematol Educ Program. 2023. PMID: 38066859
Acquired bleeding disorders.
Tiede A, Zieger B, Lisman T. Tiede A, et al. Haemophilia. 2022 May;28 Suppl 4:68-76. doi: 10.1111/hae.14548. Haemophilia. 2022. PMID: 35521729 Review.
Management of acquired haemophilia A.
Tiede A, Scharf RE, Dobbelstein C, Werwitzke S. Tiede A, et al. Hamostaseologie. 2015;35(4):311-8. doi: 10.5482/HAMO-14-11-0064. Epub 2015 Jan 7. Hamostaseologie. 2015. PMID: 25564260 Review.
Acquired bleeding disorders.
Tiede A, Zieger B, Lisman T. Tiede A, et al. Haemophilia. 2021 Feb;27 Suppl 3:5-13. doi: 10.1111/hae.14033. Epub 2020 Jun 1. Haemophilia. 2021. PMID: 32476241 Review.
170 results